The findings might provide an essential insight for epigenetics m6A modification and CD8+ T cell-mediated antitumor immunity in NSCLC (Fig. 8), which might provide a point for NSCLC immunotherapy. Here, CD8A is linked to non-small cell lung carcinoma.